Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma

BACKGROUND: The role of guanylate‐binding proteins (GBPs) in various cancers has been elucidated recently. However, our knowledge of the clinical relevance and biological characteristics of GBPs in hepatocellular carcinoma (HCC) remains limited. METHODS: A total of 955 HCC patients were enrolled fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Yumei, Fang, Shilin, Fang, Jun, Lin, Kun, Nie, Haihang, Xiong, Peiling, Qiu, Peishan, Zhao, Qiu, Wang, Haizhou, Wang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501289/
https://www.ncbi.nlm.nih.gov/pubmed/37551111
http://dx.doi.org/10.1002/cam4.6347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501289/
https://www.ncbi.nlm.nih.gov/pubmed/37551111
http://dx.doi.org/10.1002/cam4.6347

Ejemplares similares